Inhibition of tumor growth by ribozyme-mediated suppression of aberrant epidermal growth factor receptor gene expression

Journal of the National Cancer Institute
H YamazakiM Nakamura

Abstract

Amplification and rearrangement of the epidermal growth factor receptor (EGFR) gene is frequently associated with malignant gliomas. One type of EGFR mutation in primary gliomas results in overexpression of an aberrant EGFR messenger RNA (mRNA) that lacks sequences of exons II through VI of the human EGFR gene. We observed that the aberrantly spliced EGFR mRNA contains a ribozyme cleavable sequence (5'-AAG GUA AUU-3') created by the joining of EGFR exon I to exon VII. We hypothesized that an appropriately designed ribozyme RNA could mediate site-specific cleavage of the aberrant EGFR mRNA and reduce the growth of aberrant EGFR-producing tumor cells. We synthesized aberrant EGFR mRNA substrates and a sequence-specific hammerhead ribozyme (abEGFR-rib) to examine the ribozyme's activity in vitro. We also constructed an abEGFR-rib plasmid and introduced it into ERM5-1 cells, which are murine NIH3T3 cells transfected to express an aberrant EGFR complementary DNA. We measured the growth potential of the cotransfected cells in culture and in nude mice. The synthesized abEGFR-rib efficiently and specifically cleaved aberrant EGFR mRNA substrates in vitro. Expression of the transfected abEGFR-rib suppressed expression of aberrant EGFR m...Continue Reading

References

Apr 1, 1992·Proceedings of the National Academy of Sciences of the United States of America·A J WongB Vogelstein
May 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·A J EkstrandV P Collins
Jun 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·P A HumphreyD D Bigner
Mar 9, 1990·Science·N SarverJ J Rossi
Nov 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·N SugawaV P Collins
Jul 1, 1987·Proceedings of the National Academy of Sciences of the United States of America·P GunningL Kedes
Aug 13, 1987·Nature·O C Uhlenbeck
Aug 1, 1987·Molecular and Cellular Biology·C Chen, H Okayama
Sep 15, 1986·American Journal of Ophthalmology·R H MillayR C Watzke
Jul 1, 1983·Analytical Biochemistry·A P Feinberg, B Vogelstein
Apr 1, 1984·Proceedings of the National Academy of Sciences of the United States of America·P DavanlooF W Studier
Aug 2, 1994·Proceedings of the National Academy of Sciences of the United States of America·R NishikawaH J Huang
Mar 28, 1986·Science·G A ProdyG Bruening

❮ Previous
Next ❯

Citations

Jun 8, 2012·Cancer Immunology, Immunotherapy : CII·Edzard SpillnerIngke Braren
Mar 21, 2007·Cancer Chemotherapy and Pharmacology·R Longo, G Gasparini
Mar 5, 2004·International Journal of Colorectal Disease·Markus GubaChristiane Bruns
Sep 13, 2011·Cancer Microenvironment : Official Journal of the International Cancer Microenvironment Society·Sabina Pucci, Paola Mazzarelli
Sep 3, 2002·Advanced Drug Delivery Reviews·Thomas MerdanThomas Kissel
Nov 20, 1998·Current Opinion in Biotechnology·P J WelchF Wong-Staal
Nov 30, 2000·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Y OshikaY Ueyama
Jan 10, 2003·The Journal of Investigative Dermatology. Symposium Proceedings·Mohammed Kashani-Sabet
May 15, 2002·Molecular Urology·A IrieS Baba
Apr 29, 1998·Journal of the National Cancer Institute·K J Scanlon, M Kashani-Sabet
Nov 30, 2000·Biochemical and Biophysical Research Communications·C M BeauséjourR L Momparler
Sep 29, 2011·EMBO Molecular Medicine·Davide Torti, Livio Trusolino
Apr 12, 2013·Neuromolecular Medicine·B KalmanD E Post
Sep 12, 2002·Expert Opinion on Therapeutic Targets·John Goodchild
Sep 23, 2009·Expert Opinion on Therapeutic Targets·Lieven HuangRudi Beyaert
Feb 9, 2012·Expert Review of Vaccines·Catherine A Del VecchioAlbert J Wong
May 19, 2006·Expert Opinion on Biological Therapy·Sabrina OliveiraRaymond M Schiffelers
Aug 27, 2005·Expert Opinion on Biological Therapy·Apar Kishor Ganti, Anil Potti
Dec 20, 2011·British Journal of Neurosurgery·Gina Farias-EisnerE Sander Connolly
Jan 16, 2010·Cancer Investigation·Apar Kishor Ganti
Jul 19, 2001·Cancer Investigation·L Wright, P Kearney
Mar 24, 2012·Neurosurgery Clinics of North America·Joaquin Q Camara-QuintanaGordon Li
Jun 29, 2007·The International Journal of Biochemistry & Cell Biology·Roberto BiancoGiampaolo Tortora
Aug 8, 2006·Biochimica Et Biophysica Acta·Sinto SebastianAngelo Paradiso
Feb 24, 2005·Seminars in Oncology·A Craig LockhartJordan D Berlin
Jul 28, 2005·Journal of Immunological Methods·Shelly Shaki-LoewensteinItai Benhar
Mar 11, 2000·Journal of Receptor and Signal Transduction Research·A D EbertD S Salomon
Aug 21, 2013·Biomaterials·Chetan YewaleAmbikanandan Misra
Feb 18, 2015·Frontiers in Oncology·Emily PadfieldKathreena M Kurian
Jul 16, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·John Mendelsohn, Jose Baselga
Jul 9, 2004·British Journal of Cancer·B F El-Rayes, P M LoRusso
Jul 27, 2010·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Georg Karpel-MasslerMarc-Eric Halatsch
Feb 11, 2004·Endocrine Reviews·Luisa BarzonGiorgio Palù
Feb 13, 2010·Expert Opinion on Therapeutic Targets·Fei YeMing-Jun Cai

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.